Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Licensing deals
Biotech
AviadoBio secures option to rare eye disease gene therapy
England's AviadoBio is looking to China as a potential source of additional gene therapies.
James Waldron
Oct 9, 2025 8:50am
CDMO Catalent strengthens ADC pipeline with $10M Lisata pact
Oct 9, 2025 7:45am
Chiesi fertilizes Arbor's gene therapy with $2B biobucks deal
Oct 6, 2025 7:00am
AbbVie flags $2.7B R&D hit to brace investors for lower profit
Oct 6, 2025 3:27am
Kyorin pens $105M pact for Japan rights to Hinge's lupus drug
Oct 1, 2025 6:40am
Novo Holdings-backed biotech raises $205M to fill gout care gap
Sep 30, 2025 8:00am